Soren Acquisition Corp. announces IPO of 22 million units priced at $10, trading on Nasdaq as "SORNU."
Quiver AI Summary
Soren Acquisition Corp. announced the pricing of its initial public offering (IPO) of 22,000,000 units at $10.00 per unit, set to begin trading on Nasdaq under the ticker symbol “SORNU” on January 7, 2026. Each unit includes one Class A ordinary share and one-third of a redeemable warrant, which can be exercised to purchase a whole share at $11.50. The offering is expected to close on January 8, 2026, and includes an option for underwriters to purchase an additional 3,300,000 units. Soren Acquisition Corp. is a blank check company aiming to merge with a business, primarily in the healthcare industry. The management team comprises CEO Arghavan Di Rezze and CFO Jamie Weber, along with a qualified Board of Directors. The IPO process has been approved by the SEC, and the company emphasized that this announcement does not constitute an offer to sell or solicit buyers.
Potential Positives
- Soren Acquisition Corp. successfully priced its initial public offering at $10.00 per unit, signaling strong initial investor interest.
- The IPO includes 22,000,000 units, which positions the Company for significant capital raising opportunities to pursue business combinations, particularly in the healthcare industry.
- The forthcoming listing on Nasdaq under the ticker symbol “SORNU” enhances the Company’s visibility and potential for attracting investment.
- The granted over-allotment option of an additional 3,300,000 units provides flexibility for the underwriters and potential for additional capital inflow.
Potential Negatives
- Company is a blank check company, which inherently carries risks as it indicates there is no established business model or revenue stream prior to acquiring a target.
- Forward-looking statements indicate uncertainty around the completion of the offering and the use of proceeds, which may cause investor hesitation.
- Potential lack of investor confidence due to reliance on a business combination in the healthcare industry, which may face regulatory and market challenges.
FAQ
What is Soren Acquisition Corp.'s IPO date?
Soren Acquisition Corp.'s IPO is set to begin trading on January 7, 2026.
What will be the ticker symbol for Soren's units?
The ticker symbol for Soren Acquisition Corp.'s units will be "SORNU" on Nasdaq.
How many units is Soren Acquisition Corp. offering?
The company is offering 22,000,000 units at a price of $10.00 per unit.
What do the units consist of?
Each unit consists of one Class A ordinary share and one-third of a redeemable warrant.
Which industry is Soren Acquisition Corp. focused on for acquisitions?
Soren Acquisition Corp. is primarily focused on the healthcare industry for its business combination opportunities.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
Full Release
Miami, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, January 7, 2026, under the ticker symbol “SORNU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “SORN” and “SORNW,” respectively. The offering is expected to close on January 8, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any.
The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.
The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as Advisors to the Company.
BTIG, LLC is acting as sole book-running manager for the offering. Reed Smith LLP is serving as legal counsel to the Company and Walkers (Cayman) LLP is serving as Cayman Island counsel to the Company. Ellenoff Grossman & Schole LLP is serving as legal counsel to the underwriters.
The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from BTIG, LLC, 65 East 55th Street, New York, New York 10022, or by email at [email protected] or by accessing the SEC’s website, www.sec.gov.
A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and became effective on January 6, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds will be used as indicated.
Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Investor Contacts
Soren Acquisition Corp.
Arghavan Di Rezze, Chief Executive Officer
[email protected]